Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anemia × Transplantation × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 6 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Leukemia 5 Myelodysplastic Syndromes 4 Lymphoma 4 Hodgkin Disease 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Hematologic Neoplasms 3 Myeloproliferative Disorders 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell 2 Congenital Abnormalities 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myelomonocytic, Juvenile 1

Interventions

Epoetin Alfa 7 Darbepoetin alfa 5 epoetin beta 4 Cyclophosphamide 4 ACE-011 4 fludarabine 3 Busulfan 3 thymoglobulin 2 luspatercept 2 fludarabine phosphate 2 Lenalidomide 2 Cyclosporine 2 Antilymphocyte Serum 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 vactosertib 1 telapristone acetate 1 ruxolitinib 1 roxadustat 1 obinutuzumab 1 ibrutinib 1 fosphenytoin 1 ferrous sulfate 1 ferric gluconate 1 ferric carboxymaltose 1 Whole-Body Irradiation 1 Thiotepa 1 Therapeutics 1 Surveys and Questionnaires 1 Sugars 1 Sucrose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡